Sarah Maylin

3.4k total citations
76 papers, 2.2k citations indexed

About

Sarah Maylin is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Sarah Maylin has authored 76 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Epidemiology, 59 papers in Hepatology and 19 papers in Infectious Diseases. Recurrent topics in Sarah Maylin's work include Hepatitis C virus research (56 papers), Hepatitis B Virus Studies (53 papers) and Liver Disease Diagnosis and Treatment (30 papers). Sarah Maylin is often cited by papers focused on Hepatitis C virus research (56 papers), Hepatitis B Virus Studies (53 papers) and Liver Disease Diagnosis and Treatment (30 papers). Sarah Maylin collaborates with scholars based in France, Ivory Coast and United States. Sarah Maylin's co-authors include Patrick Marcellin, Nathalie Boyer, Marie–Pierre Ripault, Rami Moucari, Pierre Bédossa, Tarik Asselah, Corinne Castelnau, Constance Delaugerre, Nathalie Giuily and Dominique Valla and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and Hepatology.

In The Last Decade

Sarah Maylin

74 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sarah Maylin France 23 2.0k 1.9k 321 113 102 76 2.2k
Manfred Wiese Germany 19 1.7k 0.9× 2.0k 1.0× 185 0.6× 238 2.1× 144 1.4× 48 2.4k
Michèle Martinot‐Peignoux France 24 2.7k 1.4× 2.8k 1.4× 311 1.0× 101 0.9× 118 1.2× 49 3.1k
Carmen Gallegos Spain 8 1.1k 0.5× 1.4k 0.7× 213 0.7× 81 0.7× 276 2.7× 10 1.6k
Katja Deterding Germany 30 2.9k 1.5× 2.9k 1.5× 356 1.1× 55 0.5× 95 0.9× 119 3.3k
Ming‐Yuh Hsieh Taiwan 25 1.8k 0.9× 1.9k 1.0× 145 0.5× 35 0.3× 81 0.8× 72 2.2k
Mani Subramanian United States 17 780 0.4× 756 0.4× 206 0.6× 114 1.0× 210 2.1× 62 1.1k
Benedetta Massetto United States 23 1.9k 0.9× 1.9k 1.0× 391 1.2× 49 0.4× 82 0.8× 44 2.3k
M.P. Manns Germany 15 1.4k 0.7× 1.7k 0.9× 97 0.3× 110 1.0× 84 0.8× 47 1.9k
Lisa M. Nyberg United States 16 1.4k 0.7× 1.5k 0.8× 241 0.8× 29 0.3× 86 0.8× 39 1.7k
Hugo Fainboim Argentina 22 1.1k 0.6× 1.2k 0.6× 199 0.6× 28 0.2× 50 0.5× 54 1.4k

Countries citing papers authored by Sarah Maylin

Since Specialization
Citations

This map shows the geographic impact of Sarah Maylin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah Maylin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah Maylin more than expected).

Fields of papers citing papers by Sarah Maylin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah Maylin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah Maylin. The network helps show where Sarah Maylin may publish in the future.

Co-authorship network of co-authors of Sarah Maylin

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah Maylin. A scholar is included among the top collaborators of Sarah Maylin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah Maylin. Sarah Maylin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Salmona, Maud, et al.. (2025). Evaluation of the analytical performances of the Alinity-i HSV-1 IgG and HSV-2 IgG chemiluminescent immunoassays. Journal of Clinical Virology. 177. 105776–105776. 1 indexed citations
2.
Chaix, Marie‐Laure, Karl Stéfic, Caroline Lascoux‐Combe, et al.. (2024). Susceptibility to lenacapavir, fostemsavir and broadly neutralizing antibodies in French primary HIV‐1 infected patients in 2020–2023. Journal of Medical Virology. 96(10). e29948–e29948. 3 indexed citations
3.
Cuffel, Alexis, Sarah Maylin, Hélène Le Buanec, et al.. (2022). Humoral and cellular responses to SARS-CoV-2 BNT162b2 vaccination in allogeneic hematopoietic stem cell transplantation recipients. Vaccine. 40(33). 4682–4685. 6 indexed citations
4.
Miailhes, Patrick, Caroline Lascoux‐Combe, Sarah Maylin, et al.. (2021). Persistent HBV replication and serological response during up to 15 years of tenofovir-based antiretroviral therapy in HIV/HBV-coinfected patients: a multicentre prospective cohort study. Journal of Antimicrobial Chemotherapy. 76(11). 3009–3019. 4 indexed citations
5.
Miailhes, Patrick, Caroline Lascoux‐Combe, Sarah Maylin, et al.. (2021). Effect of Viral Replication and Liver Fibrosis on All-Cause Mortality in Human Immunodeficiency Virus–Hepatitis B Virus–Coinfected Individuals: A Retrospective Analysis of a 15-Year Longitudinal Cohort. Clinical Infectious Diseases. 74(6). 1012–1021. 4 indexed citations
6.
Thibault, Vincent, Gisèle Lagathu, Gilles Duverlie, et al.. (2019). Hepatitis C subtype distribution in chronically infected patients with mild liver fibrosis in France: the GEMHEP study. Epidemiology and Infection. 147. e234–e234. 3 indexed citations
7.
Penot, Pauline, et al.. (2018). Hepatitis A infections in men who have sex with men using HIV PrEP in Paris. BMJ Case Reports. 2018. bcr–2017. 11 indexed citations
8.
Boyd, Anders, Raoul Moh, Anani Badjé, et al.. (2017). Higher Mortality Despite Early Antiretroviral Therapy in Human Immunodeficiency Virus and Hepatitis B Virus (HBV)–Coinfected Patients With High HBV Replication. Clinical Infectious Diseases. 66(1). 112–120. 45 indexed citations
9.
Fouéré, S., Sarah Maylin, Catherine Scieux, et al.. (2016). First HSV-1 non primary genital herpes in two patients. Journal of Clinical Virology. 78. 108–110.
10.
Békondi, Claudine, Abdoulaye Seck, Benoît Garin, et al.. (2015). HBV immunization and vaccine coverage among hospitalized children in Cameroon, Central African Republic and Senegal: a cross-sectional study. BMC Infectious Diseases. 15(1). 267–267. 22 indexed citations
11.
Maylin, Sarah, Jean-Marie Sire, P.S. Mbaye, et al.. (2015). Short-term spontaneous fluctuations of HBV DNA levels in a Senegalese population with chronic hepatitis B. BMC Infectious Diseases. 15(1). 154–154. 14 indexed citations
12.
Khonsari, Roman Hossein, Sarah Maylin, Michèle Martinot‐Peignoux, et al.. (2014). Sicca Syndrome and Dementia in a Patient with Hepatitis C Infection: A Case Report with Unusual Bifocal Extrahepatic Manifestations. Journal of Maxillofacial and Oral Surgery. 14(S1). 388–392. 1 indexed citations
13.
Rey-Cuillé, Marie-Anne, Richard Njouom, Claudine Békondi, et al.. (2013). Hepatitis B Virus Exposure During Childhood in Cameroon, Central African Republic and Senegal After the Integration of HBV Vaccine in the Expanded Program on Immunization. The Pediatric Infectious Disease Journal. 32(10). 1110–1115. 20 indexed citations
14.
Maylin, Sarah, S. Fouéré, François Simon, & Constance Delaugerre. (2013). Failure of Fourth-Generation Enzyme Immunoassay in HIV Screening and Plasma HIV-1 RNA Detection in Recent High-Risk Behavior. Intervirology. 57(1). 49–51. 3 indexed citations
15.
Maylin, Sarah, Anders Boyd, Michelle Martinot-Peignoux, et al.. (2013). Quantification of hepatitis B e antigen between Elecsys HBeAg and Architect HBeAg assays among patients infected with hepatitis B virus. Journal of Clinical Virology. 56(4). 306–311. 14 indexed citations
16.
Martinot‐Peignoux, Michelle, Christiane Stern, Sarah Maylin, et al.. (2009). Twelve weeks posttreatment follow‐up is as relevant as 24 weeks to determine the sustained virologic response in patients with hepatitis C virus receiving pegylated interferon and ribavirin†. Hepatology. 51(4). 1122–1126. 120 indexed citations
17.
Maylin, Sarah, Michelle Martinot‐Peignoux, Marie–Pierre Ripault, et al.. (2009). Sustained virological response is associated with clearance of hepatitis C virus RNA and a decrease in hepatitis C virus antibody. Liver International. 29(4). 511–517. 30 indexed citations
18.
Martinot-Peignoux, Michelle, et al.. (2007). [618] OPTIMAL PRETREATMENT VIRAL LOAD CUT-OFF TO PREDICT TREATMENT OUTCOME IN PATIENTS WITH CHRONIC HEPATITIS C TREATED WITH PEGINTERFERON o-2b PLUS RIBAVIRIN. Journal of Hepatology. 46. S234–S234. 3 indexed citations
19.
Moucari, Rami, Tarik Asselah, Dominique Cazals‐Hatem, et al.. (2007). Insulin Resistance in Chronic Hepatitis C: Association With Genotypes 1 and 4, Serum HCV RNA Level, and Liver Fibrosis. Gastroenterology. 134(2). 416–423. 417 indexed citations
20.
Castelnau, Corinne, Frédéric Le Gal, Marie–Pierre Ripault, et al.. (2006). Efficacy of peginterferon alpha-2b in chronic hepatitis delta: Relevance of quantitative RT-PCR for follow-up. Hepatology. 44(3). 728–735. 162 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026